07 Jan 2001

Posorutin® (Posorutin® Augentropfen) - Deutschland

Updated: 07 Jan 2001


Als Adjuvans bei Retinopathia diabetica, Retina- u. Glaskörperblutungen, subkonjunktivale Blutungen u. Thrombosen.

Posorutin® Description, Presentation and Dosage

Posorutin® Description

Posorutin® Drug Class Description


Posorutin® Drug Description

1 ml enth.: Troxerutin 50 mg.

Posorutin® Generic Name

Posorutin® Augentropfen

Posorutin® Presentation

Posorutin® Presentation


Posorutin® Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this free resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately. Content is arranged into sections with disease awareness information, mode of action videos, first-line treatment options, links to useful external hyperammonaemia content and more… 

Posorutin® Dosage

Posorutin® Adult Dosage

Chlorhexidindigluconat 0,05 mg (Konservierungsmittel), Natriumchlorid, Dinatriumedetat, Wasser f. Inj.-zwecke.

Posorutin® Precautions, Reactions and Contraindications

Posorutin® Special Precautions

Related Drugs - Eye Health and Disorders

Back to top